Bioethics News

Laser-Activated Drug Offers New Hope for Prostate Cancer Treatment

December 20, 2016

(CNN) – A new laser-based treatment for prostate cancer has shown promise as a new therapy, without the need for surgery. In a new study, published Tuesday in the Lancet Oncology, scientists at UCL in the UK injected cancer patients with a light-sensitive chemical that, on entry into the prostate, could be activated by lasers to kill cancerous cells, while avoiding the surrounding healthy cells and tissue.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.